Loading compound...
Research compound
Clemizole is a chemical compound being studied for its potential to treat various conditions, including certain types of seizures and liver-related issues. It is currently in the research phase and is not a standard approved medication for general use.
How it worksWhile the exact way it works in the body is still being researched, Clemizole is being studied for its effects on neurological and liver conditions.
Used for
Dravet syndrome (a type of epilepsy)Lenox-Gastaut syndrome (a severe form of epilepsy)Hepatocellular carcinoma (liver cancer)Hepatitis C virus infection
Conditions
Dravet syndromeLennox-Gastaut syndromeHepatocellular carcinomaHepatitis C virus infection
Class
Small moleculeResearch compoundNervous systemHepatic (Liver)
How to take
Clemizole is currently in the research phase (Phase 1 and 2 studies) and is not yet an FDA-approved drug for these conditions.
Key warnings
- ·Laboratory data indicates potential risks to heart health (hERG inhibition and cardiotoxicity).
Side effects
Serious
- ·Potential for heart-related toxicity (cardiotoxicity) observed in laboratory studies.
Seek help if
- ·Seek medical help if you experience heart-related symptoms while participating in studies involving Clemizole.
Interactions
- ·Clemizole may interact with other drugs processed by the CYP1A2, CYP2D6, and CYP3A4 enzymes in the liver.
Talk to your doctor
Monitor
- ·Heart health/cardiac function
- ·Liver enzyme levels
Questions to ask
- ·What are the potential heart risks of Clemizole?
- ·How might Clemizole interact with my current liver medications?
- ·What stage of clinical testing is Clemizole currently in?
Pharmacokinetics
MetabolismClemizole is associated with the inhibition of CYP1A2, CYP2D6, and CYP3A4 enzymes.
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.
